A
Alexander Turchin
Researcher at Brigham and Women's Hospital
Publications - 150
Citations - 4923
Alexander Turchin is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Retrospective cohort study. The author has an hindex of 33, co-authored 132 publications receiving 4159 citations. Previous affiliations of Alexander Turchin include Tufts Medical Center & Partners HealthCare.
Papers
More filters
Journal ArticleDOI
Discontinuation of statins in routine care settings: a cohort study.
Huabing Zhang,Jorge Plutzky,Stephen Skentzos,Fritha Morrison,Perry Mar,Maria Shubina,Alexander Turchin +6 more
TL;DR: Most patients who are rechallenged can tolerate statins long-term, which suggests that many of the statin-related events may have other causes, are tolerable, or may be specific to individual statins rather than the entire drug class.
Journal ArticleDOI
Classifying and Predicting Errors of Inpatient Medication Reconciliation
Jennifer R. Pippins,Jennifer R. Pippins,Tejal K. Gandhi,Tejal K. Gandhi,Claus Hamann,Chima D. Ndumele,Stephanie Labonville,Ellen K. Diedrichsen,Marcy G. Carty,Marcy G. Carty,Andrew S. Karson,Ishir Bhan,Christopher M. Coley,Catherine Liang,Alexander Turchin,Patricia C. McCarthy,Jeffrey L. Schnipper,Jeffrey L. Schnipper +17 more
TL;DR: Focusing on accurate medication histories, on potential medication errors at discharge, and on identifying high-risk patients for more intensive interventions may improve medication safety during and after hospitalization.
Journal ArticleDOI
Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward
Alexander Turchin,Michael E. Matheny,Maria Shubina,James V. Scanlon,Bonnie C. Greenwood,Merri Pendergrass +5 more
TL;DR: Whether hypoglycemia episodes are associated with higher mortality in diabetic patients hospitalized in the general ward and the number and severity of hypoglycemic episodes and inpatient mortality, length of stay (LOS), and mortality within 1 year after discharge were evaluated.
Journal ArticleDOI
Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial.
Jeffrey L. Schnipper,Claus Hamann,Chima D. Ndumele,Catherine Liang,Marcy G. Carty,Andrew S. Karson,Ishir Bhan,Christopher M. Coley,Eric G. Poon,Alexander Turchin,Stephanie Labonville,Ellen K. Diedrichsen,Stuart R. Lipsitz,Carol A. Broverman,Patricia C. McCarthy,Tejal K. Gandhi +15 more
TL;DR: In this paper, the authors compared the extent of integration of the medication reconciliation tool into computerized provider order entry applications at discharge and found that a significant benefit was found at hospital 1 (ARR, 0.60; 95% CI, 0 38-0.97) but not at hospital 2(ARR,0.87;95%CI,0 57-1.32).
Journal ArticleDOI
Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.
Ole-Petter R. Hamnvik,Toni K. Choueiri,Alexander Turchin,Rana R. McKay,Lipika Goyal,Michael Davis,Marina D. Kaymakcalan,Jonathan S. Williams +7 more
TL;DR: The real‐world association between baseline clinical characteristics, blood pressure response, and survival in patients prescribed anti‐VEGF therapies is described.